DKA Readmission Reduction—Teaching DKA Prevention to Patients AND Nurses
Room 343
Level 3, Ernest N. Morial Convention Center
Q&A with Lisa M. Diaz, RN, MSN, CDCES, PhD Student
Inpatient/Outpatient Diabetes Program Manager,
PVHMC
What is your presentation about?
Inpatient education — teaching staff with a focus on hospital systems. Diabetic ketoacidosis (DKA) trends during and post COVID-19, and DKA readmission reduction — teaching DKA prevention to patients and nurses in the urban community hospital setting.
What makes this topic important in 2022?
DKA is still a very serious threat to many patients with diabetes, with the face of DKA changing during and post COVID-19.
How did you become involved with this area of diabetes research or care?
I became the lead for a hospital-based diabetes program, principal investigator for a grant-funded project titled, “Stopping Diabetes in its Tracks” (SDIT). The diabetes self-management education (DSME) intervention targeted a largely Hispanic population, taking into great consideration language, cultural particularities, education, and health literacy. Careful study design and utilization of a Hispanic cultural lens, I believe, led to the positive outcomes. Those results, and the new partnerships formed are the reasons why dedicating the next four years to nursing PhD studies is so important to me.
What are you most looking forward to at the 82nd Scientific Sessions?
Looking forward to meeting researchers in diabetes and healthcare as I get ready to start my PhD studies this fall 2022 at the UCLA School of Nursing. As well, I will share my own experience leading an inpatient joint commission recognized program and more recently a DSME program.
[sub-post-content]